Tronc Inc (NASDAQ:TRNC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Tronc Inc is a multimedia company. It operates in publishing, digital and broadcasting businesses. Tronc Inc has a market cap of $561.620 million; its shares were traded at around $15.77 with a P/E ratio of 87.61 and P/S ratio of 0.36.
For the last quarter Tronc Inc reported a revenue of $435.0 million, compared with the revenue of $425.4 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.5 billion, a decrease of 5.1% from the previous year. For the last five years Tronc Inc had an average revenue decline of 4.2% a year.
The reported diluted earnings per share was 16 cents for the year, a decline of 15.8% from the previous year. The Tronc Inc had an operating margin of 4.37%, compared with the operating margin of 3.31% a year before. The 10-year historical median operating margin of Tronc Inc is 3.31%. The profitability rank of the company is 6 (out of 10).
Top 5 Clean Energy Stocks To Invest In 2021: CTI BioPharma Corp.(CTIC)
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and health care providers. Our goal is to build a profitable company by generating income from products we develop and commercialize, either alone or with partners. We are currently concentrating our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are primarily focused on commercializing PIXUVRI in select countries in the European Union, or the E.U., for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma, or NHL, and evaluating pacritinib for the treatment of adult patients with myelofibrosis. PIXUVRI PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Advisors' Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on CTI BioPharma (CTIC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Steve Symington]
Nevertheless, several individual stocks failed to keep up. Read on to see why CTI BioPharma (NASDAQ:CTIC), PetMed Express (NASDAQ:PETS), and Pfizer (NYSE:PFE) each slumped today.
- [By Brian Feroldi]
In response to the company sharing a clinical update, shares of CTI BioPharma (NASDAQ:CTIC), a clinical-stage biotech focused on blood-related cancers, fell 13% as of 12:05 p.m. EDT on Monday.
- [By Joseph Griffin]
Shares of CTI BioPharma Corp (NASDAQ:CTIC) have received an average recommendation of “Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $7.10.
Top 5 Clean Energy Stocks To Invest In 2021: ESSA Pharma Inc.(EPIX)
ESSA Pharma, Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is developing drugs that selectively block the N-terminal domain (NTD) of the androgen receptor (AR). Its segment is the development of small molecule drugs for prostate cancer. Its product candidate, EPI-506, is an oral small molecule pro-drug that blocks the NTD of the AR. The Company has initiated a Phase I/II clinical trial to determine the tolerability, maximum tolerated dose, pharmacokinetics and potential therapeutic benefits of EPI-506 in castration-resistant prostate cancer (CRPC) patients. In Phase I, the trial will evaluate the tolerability, pharmacokinetics and maximum-tolerated dose of EPI-506 in multiple-dose escalations. The Phase II portion (dose expansion) of the trial will then evaluate activity in over three patient cohorts: post-enzalutamide CRPC, post-abiraterone CRPC, and both post-enzalutamide and post-abiraterone CRPC. Advisors' Opinion:- [By Stephan Byrd]
Avid Bioservices (NASDAQ:CDMO) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Clean Energy Stocks To Invest In 2021: NESTLE SA(NSRGY)
Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. The company operates through Zone Europe, Middle East and North Africa; Zone Americas; Zone Asia, Oceania and sub-Saharan Africa; and Nestlé Waters segments. It offers baby foods under the Cerelac, Gerber, and NaturNes brands; bottled water under the Nestlé Pure Life, Perrier, Poland Spring, and S.Pellegrino brands; cereals under the Fitness, Nesquik, cheerios, and Lion Cereals brands; and chocolate and confectionery products under the KitKat, Nestle L'atelier, Nestle Toll House, Milkybar, Smarties, Quality Street, Aero, Garoto, Orion, and Cailler brands. The company also provides coffee products under the Nescafé original, Nespresso, Nescafé Dolce Gusto, Nescafé, Nescafé Original 3 in 1, Coffee-Mate, Nescafé Gold, and Nescafé Cappuccino brands; culinary, chilled, and frozen foods under the Maggi, Hot Pockets, Stouffer's, Thomy, Jacks, TombStone, Buitoni, DiGiorno, and Lean Cuisine brands; dairy products under the Carnation, Nido, Coffee-Mate, and La Laitière brands; and drinks under the Nesquik, Nestea, and Milo brands. In addition, it offers food service products under the Milo, Nescafé, Maggi, Chef, Nestea, Stouffer's, Chef-Mate, Sjora, Minor's, and Lean Cuisine brand names; healthcare nutrition products under the Boost, Peptamen, Resource, and Nutren Junior brands; ice cream products under the Dreyer's, Mövenpick, Häagen-Dazs, Nestlé Ice Cream, and Extrême brands; and pet care products under the Purina, ONE, Alpo, Felix, Pro Plan, Cat Chow, Fancy Feast, Chef Michael's, Bakers, Friskies, Dog Chow, Beneful, and Gourmet brands. Further, it provides coffee creamers under the Starbucks brand. The company was founded in 1866 and is headquartered in Vevey, Switzerland.
Advisors' Opinion:- [By ]
Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you'll find shares of The Industrial & Commercial Bank of China Ltd. (IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland's Nestlé (NSRGY), the largest food company in the world; China's Tencent (TCEHY), one of the country's largest internet service providers; and Japanese gaming giant Nintendo (NTDOY).
- [By Ethan Ryder]
Capital Management Associates NY decreased its holdings in NESTLE S A/S (OTCMKTS:NSRGY) by 15.2% in the 4th quarter, HoldingsChannel reports. The firm owned 2,800 shares of the company’s stock after selling 500 shares during the period. Capital Management Associates NY’s holdings in NESTLE S A/S were worth $227,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on NESTLE S A/S (NSRGY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
South Texas Money Management Ltd. acquired a new stake in shares of NESTLE S A/S (OTCMKTS:NSRGY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,677 shares of the company’s stock, valued at approximately $2,840,000.
Top 5 Clean Energy Stocks To Invest In 2021: United Financial Bancorp Inc.(UBNK)
United Financial Bancorp, Inc. operates as a holding company for United Bank that provides various banking products and services in Massachusetts. It provides a range of deposit products, including demand accounts, NOW accounts, money market accounts, savings accounts, retirement accounts, and certificates of deposits. The company?s loan portfolio consists of one- to four-family residential mortgage loans, commercial real estate loans, construction loans, home equity loans and home equity lines of credit, commercial and industrial loans, and automobile loans, as well as consumer loans comprising secured and unsecured personal loans, motorcycle and motor home loans, manufactured housing, boat loans, and pool and spa loans. In addition, it offers non-deposit investment products and financial planning services comprising mutual funds; debt, equity, and government securities; insurance products; fixed and variable annuities; financial planning for individual and commercial cu stomers; and estate planning services. Further, the company engages in buying, selling, and holding investment securities; and holding real estate assets. It operates 22 full-service banking offices and 2 financial services facilities. The company was founded in 1882 and is headquartered in West Springfield, Massachusetts.
Advisors' Opinion:- [By Motley Fool Transcribers]
United Financial Bancorp Inc (NASDAQ:UBNK)Q1 2019 Earnings CallApril 17, 2019, 10:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
United Financial Bancorp (NASDAQ:UBNK) will post its quarterly earnings results before the market opens on Tuesday, October 16th. Analysts expect United Financial Bancorp to post earnings of $0.30 per share for the quarter.
- [By Max Byerly]
Hennessy Advisors Inc. cut its holdings in United Financial Bancorp Inc (NASDAQ:UBNK) by 4.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 235,000 shares of the bank’s stock after selling 10,000 shares during the quarter. Hennessy Advisors Inc.’s holdings in United Financial Bancorp were worth $3,955,000 as of its most recent SEC filing.
- [By Ethan Ryder]
United Financial Bancorp (NASDAQ:UBNK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “United Financial Bancorp, Inc. is the holding company for United Bank, a full service financial services firm offering a complete line of commercial, business, and consumer banking products and services. The Company is primarily engaged in the business of directing, planning, and coordinating the business activities of the Bank. United Financial Bancorp, Inc. is based in Connecticut. “
Top 5 Clean Energy Stocks To Invest In 2021: Host Hotels & Resorts, Inc.(HST)
Host Hotels & Resorts, Inc. (Host Inc.), incorporated on September 28, 1998, operates as a self-managed and self-administered real estate investment trust (REIT). The Company operates through hotel ownership segment. The Company owns properties and conducts operations through Host Hotels & Resorts, L.P. (Host L.P.), of which Host Inc. is the sole general partner and in which it holds approximately 99% of the partnership interests (OP units). The Company's portfolio consists of luxury and upper upscale properties located in the central business districts of cities, near airports and resort/conference destinations. In addition to its consolidated hotel portfolio, the Company also owns non-controlling interests in several entities and owned interest in approximately 20 hotel properties.
The Company's lodging portfolio consists of over 100 luxury and upper-upscale hotels containing approximately 57,000 rooms, with the majority located in the United States and with approximately 20 of the properties located outside of the United States, in Australia, Brazil, Canada, Chile, Mexico and New Zealand. In addition, the Company owns non-controlling interests in two international joint ventures: a joint venture in Europe, which owns approximately 10 luxury and upper upscale hotels with approximately 3,900 rooms in Belgium, France, Germany, Spain, Sweden, the Netherlands and the United Kingdom, and another joint venture, which holds interest in approximately five operating hotels in India and over two additional hotels, which are under development. It also holds non-controlling investments in approximately two domestic hotels and a timeshare joint venture in Hawaii. The Company's hotels operate in urban and resort markets under brand names as Fairmont, Grand Hyatt, JW Marriott, Ritz-Carlton, St. Regis, The Luxury Collection and W, or as upper upscale properties under brand names as Embassy Suites, Hilton, Hyatt, Le Meridien, Marriott Executive Apartments, Marriott Marquis, Marriott Suites, Pullman, Ren! aissance, Sheraton, Swissotel and Westin.
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Host Hotels and Resorts (HST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Decision Token (CURRENCY:HST) traded up 0.4% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on August 1st. Over the last seven days, Decision Token has traded 14.3% lower against the U.S. dollar. Decision Token has a total market cap of $9.44 million and approximately $37,782.00 worth of Decision Token was traded on exchanges in the last day. One Decision Token token can now be purchased for $0.29 or 0.00003853 BTC on major exchanges including Cryptopia, Livecoin and Kucoin.
- [By Shane Hupp]
Krueger & Catalano Capital Partners LLC acquired a new stake in Host Hotels and Resorts Inc (NYSE:HST) during the second quarter, HoldingsChannel.com reports. The fund acquired 42,846 shares of the real estate investment trust’s stock, valued at approximately $903,000.
No comments:
Post a Comment